Insmed Incorporated (INSM) scores 47 out of 100 on boothcheck's 11-model valuation framework. Verdict: Avoid The estimated fair value is $-40.55, representing a 254% premium to fair value.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.